At the Association for Mass Spectrometry's Applications to the Clinical Lab meeting this week, proteomics researchers highlighted the need for higher-throughput assays, with several introducing automated SISCAPA workflows employing instruments from vendors including Agilent Technologies and Thermo Fisher Scientific.
AB Sciex's new TripleTOF 5600 and Waters' new Xevo G2 QTof will enable researchers to run qualitative and quantitative workflows simultaneously, the companies said, allowing for full scans of complex samples that can then be interrogated in a more targeted fashion.
The anticipated weak mass-spec market has not stopped vendors from launching new instruments, which may pay off later in the year when spending from the economic stimulus package could hit instrument manufacturers.
At ABRF’s annual conference this week, its various research groups presented preliminary results from their studies. One study found that clinical labs had trouble detecting PSA using standard ELISAs, which to some degree was a validation of proteomics.